Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome
Seong‐Kyu Kim, Jung‐Yoon Choe, Geon Ho Lee
Clinica Chimica Acta (2017) Vol. 474, pp. 147-154
Closed Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Melatonin: a potential therapeutic approach for the management of primary Sjögren’s syndrome
Yi Liu, Ya‐Qin Tan, Gang Zhou
Immunologic Research (2023) Vol. 71, Iss. 3, pp. 373-387
Closed Access | Times Cited: 5
Immunopathogenesis of Sjogren's syndrome: Current state of DAMPs
Bingxia Ming, Yaowu Zhu, Jixin Zhong, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 56, pp. 152062-152062
Closed Access | Times Cited: 8
Network pharmacology identifies the inhibitory effect of Yiqiyangyinquyu prescription on salivary gland inflammation in Sjögren’s syndrome
Tao Hong, Chen Wu, Yating Ren, et al.
Medicine (2023) Vol. 102, Iss. 47, pp. e36144-e36144
Open Access | Times Cited: 4
Iguratimod Alleviates Experimental Sjögren’s Syndrome by Inhibiting NLRP3 Inflammasome Activation
Qi Zhang, Xi-Rui Yang, Yao Deng
Cell Biochemistry and Biophysics (2024)
Closed Access | Times Cited: 1
A comprehensive review of Sjögren's syndrome: classification criteria, risk factors, and signaling pathways
Ting Zhao, Runrun Zhang, Zhaofu Li, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36220-e36220
Open Access | Times Cited: 1
Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren’s Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
Rossella Talotta, Piercarlo Sarzi‐Puttini, Fabiola Atzeni
Journal of Immunology Research (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 10
Huoxue Jiedu Recipe represses mitochondrial fission to alleviate submandibular gland inflammation in Sjögren's syndrome
Jiangxi Xu, Zhengdong Shen, Yun Du, et al.
Microbiology and Immunology (2023) Vol. 67, Iss. 8, pp. 377-387
Closed Access | Times Cited: 3
Total glucosides of paeony alleviates experimental Sjögren's syndrome through inhibiting NLRP3 inflammasome activation of submandibular gland cells
Tingting Jiang, Junqiao Guo, Yue Wang, et al.
Clinical and Experimental Rheumatology (2023)
Open Access | Times Cited: 3
The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study
Jasvinder A. Singh, John D. Cleveland
Joint Bone Spine (2019) Vol. 86, Iss. 5, pp. 615-619
Closed Access | Times Cited: 5
+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
Charalampos Skarlis, Nikolaos Marketos, Adrianos Nezos, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3960-3960
Open Access | Times Cited: 5
In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome
Jayakanthan Kabeerdoss, Pulukool Sandhya, Biji T. Kurien, et al.
Rheumatology International (2021) Vol. 42, Iss. 3, pp. 545-551
Closed Access | Times Cited: 4
Identification of potential biomarkers for SLE through mRNA expression profiling
S Rizk, Amal Alhosary, Enas S. Zahran, et al.
Journal of Immunoassay and Immunochemistry (2023) Vol. 45, Iss. 1, pp. 20-37
Closed Access | Times Cited: 1
A Comprehensive Review of Sjögren's Syndrome, Classification Criteria, Risk Factors and Signaling Pathways
Ting Zhao, Runrun Zhang, Zhaofu Li, et al.
(2024)
Closed Access
Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases
Ranjeet Singh Mahla, Esther L. Jones, Lynn B. Dustin
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7705-7705
Open Access
Clinical significance of progranulin correlated with serum soluble Oxford 40 ligand in primary Sjögren's syndrome
Xuan Qi, Huifang Guo, Chao Sun, et al.
Medicine (2020) Vol. 99, Iss. 18, pp. e19967-e19967
Open Access | Times Cited: 1
Studies of the Systemic Inflammation in Psoriasis
Gunnthorunn Sigurdardottir
Linköping University medical dissertations (2018)
Open Access
Risque de syndrome de Gougerot-Sjögren chez les personnes âgées souffrant de goutte : étude basée sur le système de sécurité sociale Medicare
Jasvinder A. Singh, John D. Cleveland
Revue du Rhumatisme (2020) Vol. 87, Iss. 2, pp. 110-115
Closed Access
The NLRP3 inflammasome pathway in autoimmune diseases: a chronotherapeutic perspective?
Cécilia Bellengier, Hélène Duez, Benoît Pourcet
Elsevier eBooks (2022), pp. 149-178
Closed Access
Effect of Moringa oleifera leaf extract on salivary gland damage in Sjögren's syndrome mice model
Agus Joko Susanto, Bambang Purwanto, Ambar Mudigdo, et al.
F1000Research (2022) Vol. 11, pp. 1263-1263
Open Access
Identification and verification of inflammatory biomarkers for primary sjögren’s syndrome
Xiaodan Liu, Haojie Wang, Xiao Wang, et al.
Research Square (Research Square) (2022)
Open Access
Previous Page - Page 2

Scroll to top